Search Results
42 results found for "SME business development consulting"
- From Mirror to Market: The Shift Every Biotech Growth Strategy Needs to Succeed
development lead inside the company Milestones are all clinical with no market-facing metrics. Because while the science is moving forward, the business is standing still . 👉 When you ignore early finalize a clinical path until they know what partners care about, what endpoints matter, and how co-development Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- Scaling Without a System? That’s a Risk You Can’t Afford Right Now
And most importantly, it frees you from being the brain of the business . So how do you start building something like this without getting buried in templates and admin? Let’s create your roadmap for enduring success. 👉 Book a 1:1 consult and start building the mindset
- Escaping the Science Trap: A Real Biotech Commercialization Strategy for Founders
the excitement is quietly giving way to a more uncomfortable reality: the science is moving, but the business In business , the goal is speed and relevance. You optimize for traction, feedback, and fit. It means aligning your breakthrough with a business model. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- Biotech Is Not a Research Project: Start Building a Company, Not Just Science
Because what works in a lab doesn't automatically work in a business. Not just publication-ready data. 2️⃣ You can define your next three milestones in business terms. It is a business that needs direction, decisions, and delivery. You do not just need great science. ✅ Set business milestones: Define what progress means beyond experiments. It’s about making the right strategic calls before your rivals do. ✅ Book your consultation — and start
- Biotech Licensing Strategy: The Hidden Terms That Scare Investors
Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not trade-offs, or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult
- Why Biotech Investors Keep Asking the Wrong Questions
. ✅ Clean PK PD ✅ A validated mechanism of action ✅ Consistent dose curves ✅ Promising in vivo results Sometimes they add more business buzzwords, hoping it will help them sound more “investor-ready.” Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- No Regulatory Strategy, No Funding: The Risk Biotech Founders Ignore Too Long
Instead of burying regulatory updates in appendix slides, the smartest founders bring them forward. It turns complexity into confidence. ✅ If you’re building a business around breakthrough science, don Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- Clarity Beats Certainty: The Strategy Advantage in Early-Stage Biotech
But when that mindset crosses into the business side of your startup, it can stall progress . your critical milestones — and which ones are still assumptions You connect scientific outputs to business Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- Biotech Complexity Risk: Why “Too Smart” Startups Fail to Scale
Misalignment between scientific and business priorities A burn rate that had nearly doubled No clear Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- How to Keep Your Biotech Startup Competitive Amid Rapid Tech Change
Technologies evolve, investor expectations shift, and the benchmarks for scientific and business progress And they don’t require a big pivot — just consistent strategic upgrades. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- Strategy Before Tactics: The Step Most Biotech Startups Skip
Business leads experiment with GTM ideas. The team is busy, experiments are running, meetings are happening. development isn’t about chasing every opportunity. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
- From Delegation to Strategy: The Hidden Key to Scaling Biotech Startups
Business-first founders, on the other hand, may hesitate to hand off critical investor or partnership Business Development Lead (BD): Adds the most value by building partnerships, cultivating investors, But they should not be tasked with visionary strategy or creative business development. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult
